Status:
RECRUITING
Cerebellar Mutism Syndrome Study
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Odense University Hospital
Aarhus University Hospital
Conditions:
Infratentorial Neoplasms
Mutism
Eligibility:
All Genders
Up to 18 years
Brief Summary
The purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the pur...
Detailed Description
Background: Cancer accounts for 22 % of all deaths among children in Europe and is thus the leading non-traumatic pediatric cause of death. Central nervous system (CNS) tumours constitute 25% of all ...
Eligibility Criteria
Inclusion
- Age \< 18 years at the date of first imaging showing this tumour
- Tumour in the cerebellum/4th ventricle/brainstem with intention to treat with surgical resection or open biopsy. Second and further surgeries are also included.
- Informed consent from custodial parent(s)
Exclusion
- None
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT02300766
Start Date
October 1 2014
End Date
December 31 2028
Last Update
September 26 2025
Active Locations (30)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria
2
University Hospital Leuven
Leuven, Belgium
3
Motol University Hospital
Prague, Czechia
4
Aalborg University Hospital
Aalborg, Denmark, 9100